Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes
Kathryn B. Holroyd, Brian C. Healy, Sarah Conway, Maria K. Houtchens, Rohit Bakshi, Shamik Bhattacharyya, Gauruv Bose, Kristin Galetta, Tamara Kaplan, Christopher Severson, Tarun Singhal, Lynn Stazzone, Jonathan Zurawski, Mariann Polgar‐Turcsanyi, Shrishti Saxena, Anu Paul, Bonnie I. Glanz, Howard L. Weiner, Tanuja Chitnis
Topics & Concepts
MedicineFingolimodNatalizumabMultiple sclerosisImmunologyVaccinationRituximabInternal medicineAntibodyMultiple Sclerosis Research StudiesSARS-CoV-2 and COVID-19 ResearchPeripheral Neuropathies and Disorders